Acute Lower Gastrointestinal Bleeding in an Emergency Department and Performance of the SHA(2)PE Score: A Retrospective Observational Study - Cerruti, T.; Maillard, M. H.; Hugli, O. (J Clin Med, 2021)
Lower gastrointestinal bleeding (LGIB) is a frequent cause of emergency department (ED) consultation, leading to investigations but rarely to urgent therapeutic interventions. The SHA(2)PE score aims to predict the risk of hospital-based intervention, but has never been externally validated. The aim of our single-center retrospective study was to describe patients consulting our ED for LGIB and to test the validity of the SHA(2)PE score. We included 251 adult patients who consulted in 2017 for hematochezia of <24 h duration; 53% were male, and the median age was 54 years. The most frequent cause of LGIB was unknown (38%), followed by diverticular disease and hemorrhoids (14%); 20% had an intervention. Compared with the no-intervention group, the intervention group was 26.5 years older, had more frequent bleeding in the ED (47% vs. 8%) and more frequent hypotension (8.2% vs. 1.1%), more often received antiplatelet drugs (43% vs. 18%) and anticoagulation therapy (28% vs. 9.5%), more often had a hemoglobin level of <10.5 g/dl (49% vs. 6.2%) on admission, and had greater in-hospital mortality (8.2% vs. 0.5%) (all p < 0.05). The interventions included transfusion (65%), endoscopic hemostasis (47%), embolization (8.2%), and surgery (4%). The SHA(2)PE score predicted an intervention with sensitivity of 71% (95% confidence interval: 66-83%), specificity of 81% (74-86%), and positive and negative predictive values of 53% (40-65%) and 90% (84-95%), respectively. SHA(2)PE performance was inferior to that in the original study, with a 1 in 10 chance of erroneously discharging a patient for outpatient intervention. Larger prospective validation studies are needed before the SHA(2)PE score can be recommended to guide LGIB patient management in the ED.
Keywords: journalArticle; hematochezia; lower gastrointestinal bleeding; score